Company Filing History:
Years Active: 2021-2022
Title: Rina Diana Fong: Innovator in Oncology and Pharmaceuticals
Introduction
Rina Diana Fong is a notable inventor based in San Diego, CA, who has made significant contributions to the fields of medicine and pharmaceuticals. With a focus on oncology, she has developed innovative solutions aimed at treating bone lesions caused by malignant neoplasms. Her work has resulted in the issuance of 2 patents that showcase her expertise and dedication to improving patient care.
Latest Patents
Rina's latest patents include a stable dosage form of etidronate-cytarabine conjugate, which ensures the hydrolytic and physical stability of the preparation. This novel dosage form is a lyophilizate that comprises an etidronate-cytarabine conjugate or a pharmaceutically acceptable salt, along with a stabilizer. The stabilizer is a divalent metal salt, and the molar ratio of stabilizer to conjugate ranges from 1:1 to 20:1. This invention is crucial for maintaining the stability of the conjugate during long-term storage and clinical use.
Another significant patent focuses on a pharmaceutical preparation for treating bone lesions caused by malignant neoplasms. This medicinal drug is presented as a lyophilisate for solution for parenteral administration. It includes a pharmaceutically acceptable salt of the divalent metal and a specific compound with a defined molar ratio. The treatment method involves administering the drug solution through intravenous drop infusions, allowing for a reduction in the metabolic activity of bone lesions caused by malignant tumors.
Career Highlights
Rina Diana Fong is associated with Maxwell Biotech Group Ltd., where she continues to innovate in the pharmaceutical sector. Her work is characterized by a commitment to developing effective treatments that address critical health challenges.
Collaborations
Rina collaborates with talented individuals such as Ekaterina Alekseevna Ivanova and Alexander Karpeisky, contributing to a dynamic research environment that fosters innovation and progress in the field.
Conclusion
Rina Diana Fong's contributions to oncology and pharmaceuticals exemplify her dedication to improving patient outcomes through innovative solutions. Her patents reflect a deep understanding of the complexities involved in drug formulation and treatment methodologies.